Addictive Disorders and Behavioral Dyscontrol
Cannabis use and dependence among French schizophrenic inpatients Michel Lejoyeux
Journal Name:
Frontiers in Psychiatry
ISSN:
1664-0640
Article type:
Original Research Article
Received on:
27 Feb 2014
Accepted on:
29 Jun 2014
Provisional PDF published on:
29 Jun 2014
www.frontiersin.org:
www.frontiersin.org
Citation:
Lejoyeux M(2014) Cannabis use and dependence among French schizophrenic inpatients. Front. Psychiatry 5:82. doi:10.3389/fpsyt.2014.00082
Copyright statement:
© 2014 Lejoyeux. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
This Provisional PDF corresponds to the article as it appeared upon acceptance, after rigorous peer-review. Fully formatted PDF and full text (HTML) versions will be made available soon.
Original research: Cannabis use and dependence among French schizophrenic inpatients Michel Lejoyeux*, Anne Basquin, Marie Koch, Houcine Embouazza, Florence Chalvin, Michaelle Ilongo. Department of psychiatry and addictive medicine. Maison Blanche Hospital and BichatClaude Bernard Hospital. AP-HP, Paris, France. Paris Diderot University. Corresponding Author : Michel Lejoyeux. Department of psychiatry and addictive medicine. AP- HP, Bichat Hospital and Maison Blanche Hospital. 75877 Paris Cedex 18. France. Phone : 33 1 40 25 82 62 Fax : 33 1 40 25 67 80 E-mail :
[email protected] Cannabis use among schizophrenic inpatients.
1
Abstract Background: To assess the prevalence of cannabis use and dependence in a population of schizophrenic inpatients and to compare schizophrenics with and without cannabis consumption. Methods: 101 schizophrenic patients were examined during their first week of hospitalization. They answered the PANNS scale of schizophrenia, the CAGE and the Fagerström questionnaire and the DSM-IV-TR criteria for cannabis, alcohol, opiates and nicotine use dependence were checked. We also assessed socio-demographic characteristics, the motive of cannabis consumption and the number of cannabis joints and alcoholic drinks taken. Results: The prevalence of cannabis consumption was 33.6% among schizophrenic inpatients. Schizophrenics consuming cannabis were younger than non-schizophrenics (33.3 vs 44.7 years p